Chronic Lung Disease of Prematurity Recruiting Phase 2 Trials for Mecasermin (DB01277)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03253263A Clinical Efficacy and Safety Study of SHP607 in Preventing Chronic Lung Disease in Extremely Premature InfantsPrevention